Cannaisseur Group Inc. (TCRG): Cost of Revenue

Annual figures by period end, from SEC filings.

$910

Year ended 2025-12-31

$582

Trailing 12 months to 2026-06-30

-72.3%

3-year compound annual growth

2022-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$910	-78.7%	2026-03-23, From 2025-01-01
2024-12-31	$4.3K	-84.2%	2026-03-23, From 2024-01-01
2023-12-31	$27.0K	-37.0%	2025-03-21, From 2023-01-01
2022-12-31	$42.8K	n/a	2024-04-15, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Cannaisseur Group Inc. (TCRG)	2025-12-31	$910	-78.7%
Cyanotech Corp (CYAN)	2025-03-31	$17.34M	+1.2%
Natural Alternatives International Inc (NAII)	2026-06-30	$133.52M	+10.7%
C21 Investments Inc. (CWLXF)	2026-03-31	$19.01M	+8.3%
USANA Health Sciences Inc (USNA)	2026-01-03	$200.85M	+24.6%
Mannatech Inc (MTEX)	2025-12-31	$27.08M	+2.5%
Nutra Pharma Corp (NPHC)	2025-12-31	$183.7K	+116.5%
Charlie's Holdings, Inc. (CHUC)	2025-12-31	$15.26M	+212.2%
Adia Med, Inc. (ADIA)	2025-12-31	$508.8K	n/m

Compare TCRG, CYAN, NAII, CWLXF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗